顔面関節注射の世界市場レポート 2025年

顔面関節注射市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR6.7％で38億5,000万米ドルに成長します。予測期間における成長の原動力は、非オピオイド系疼痛管理オプションに対する需要の高まり、画像誘導注射技術の採用拡大、外来・デイケア処置の重視、再生注射療法の利用拡大、脊椎疾患治療へのヘルスケア投資の拡大です。この間に予想される主な動向には、超音波および透視ガイド下注射の改善、疼痛緩和を長時間持続させるための高度な薬剤製剤の開発、関節痛に対する併用療法の創出、多血小板血漿や幹細胞などの再生治療の革新、注射後のモニタリングのためのウェアラブル技術の進歩などがあります。

脊椎疾患と慢性腰痛の有病率の増加は、今後の顔面関節注射市場の成長を牽引すると予想されます。椎間板変性、関節炎、神経圧迫を含むこれらの疾患は、継続的な痛み、運動制限、生活の質の低下を引き起こします。脊椎疾患や慢性腰痛の増加は、座りっぱなしのライフスタイルや姿勢の悪さが主な原因であり、持続的な不快感を和らげ、動きを回復させる効果的で破壊の少ない治療を求める人が増えています。ファセット・ジョイント注射は、背骨の痛みと炎症を軽減することで、これらの増大する背骨の健康問題に罹患している人々を支援します。例えば、2023年5月、米国を拠点とする非営利リソースセンターであるSpinal Cord Inc.は、米国では年間約1万8,000件の脊髄損傷症例が新たに発生し、全国で推定30万2,000人が脊髄損傷とともに生活していると報告しました。その結果、脊椎疾患と慢性腰痛の有病率の増加が顔面関節注射市場の拡大に拍車をかけています。

低侵襲処置に対する需要の増加が、今後数年間の顔面関節注射市場の成長を促進すると予想されます。低侵襲治療とは、小さな切開で、あるいは大きな外科的切開をせずに行う治療を指します。患者の早期回復や術後疼痛の軽減に対する嗜好から、その人気は高まっています。ファセット・ジョイント注射は、大がかりな手術を必要とせず、正確な鎮痛と診断の明瞭さを提供することで、こうした手技を支えています。例えば、米国を拠点とする専門組織である米国形成外科学会は2023年、低侵襲美容整形手術の件数が2022年の2,370万件から2,540万件に増加したと報告しています。その結果、低侵襲治療に対する需要の高まりが顔面関節注射市場の拡大に拍車をかけています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、貿易戦争と関税、そしてコロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の顔面関節注射：PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の顔面関節注射市場：成長率分析
• 世界の顔面関節注射市場の実績：規模と成長、2019年～2024年
• 世界の顔面関節注射市場の予測：規模と成長、2024年～2029年、2034年
• 世界の顔面関節注射：総潜在市場規模（TAM）

第6章 市場セグメンテーション

• 世界の顔面関節注射市場：製品タイプ別、実績と予測、2019年～2024年、2024年～2029年、2034年
• コルチコステロイド
• 局所麻酔薬
• ヒアルロン酸
• その他の製品タイプ
• 世界の顔面関節注射市場：用途別、実績と予測、2019年～2024年、2024年～2029年、2034年
• 頸椎椎間関節
• 胸椎椎間関節
• 腰椎椎間関節
• 椎間関節注射
• 世界の顔面関節注射市場：エンドユーザー別、実績と予測、2019年～2024年、2024年～2029年、2034年
• 病院
• 外来手術センター
• 専門クリニック
• その他のエンドユーザー
• 世界の顔面関節注射市場、コルチコステロイドの種類別サブセグメンテーション、実績と予測、2019年～2024年、2024年～2029年、2034年
• トリアムシノロンアセトニド
• メチルプレドニゾロン酢酸塩
• デキサメタゾンリン酸ナトリウム
• ベタメタゾン
• その他のコルチコステロイド
• 世界の顔面関節注射市場、局所麻酔薬の種類別サブセグメンテーション、実績と予測、2019年～2024年、2024年～2029年、2034年
• リドカイン
• ブピバカイン
• ロピバカイン
• プリロカイン
• その他の局所麻酔薬
• 世界の顔面関節注射市場、ヒアルロン酸の種類別サブセグメンテーション、実績と予測、2019年～2024年、2024年～2029年、2034年
• 高分子量ヒアルロン酸
• 低分子量ヒアルロン酸
• 架橋ヒアルロン酸
• 非架橋ヒアルロン酸
• 世界の顔面関節注射市場、その他の製品タイプのサブセグメンテーション、タイプ別、実績と予測、2019年～2024年、2024年～2029年、2034年
• 多血小板血漿
• 生物学的因子
• 複合製剤
• その他の注射剤

第7章 地域別・国別分析

• 世界の顔面関節注射市場：地域別、実績と予測、2019年～2024年、2024年～2029年、2034年
• 世界の顔面関節注射市場：国別、実績と予測、2019年～2024年、2024年～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 顔面関節注射市場：競合情勢
• 顔面関節注射市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co. Inc Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • Medtronic plc Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Stryker Corporation
• Teva Pharmaceutical Industries Ltd.
• Boston Scientific Corporation
• Henry Schein Inc.
• Bausch Health Companies Inc.
• Zimmer Biomet Holdings Inc.
• Smith & Nephew plc
• Dr. Reddy's Laboratories Ltd.
• Arthrex Inc.
• Aspen Pharmacare Holdings Limited
• Pacira BioSciences Inc.
• Bioventus Inc.
• Ferring Pharmaceuticals
• Anika Therapeutics Inc.
• Symbiotec Pharmalab Pvt. Ltd.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 顔面関節注射市場2029年：新たな機会を提供する国
• 顔面関節注射市場2029年：新たな機会を提供するセグメント
• 顔面関節注射市場2029年：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

A facet joint injection is a minimally invasive procedure designed to diagnose or treat pain originating from the facet joints, which are small joints located between pairs of vertebrae in the spine. The injection usually contains a mix of a local anesthetic to numb the area and a corticosteroid to reduce inflammation. This procedure is often used to alleviate chronic pain in the neck, back, or thoracic region caused by arthritis or spinal degeneration.

The primary types of products used in facet joint injections include corticosteroids, local anesthetics, hyaluronic acid, and others. Corticosteroids are steroid hormones utilized medically to decrease inflammation and suppress immune responses. These injections are applied to various regions such as the cervical, thoracic, and lumbar facet joints, and are administered by a range of end-users including hospitals, ambulatory surgical centers, specialty clinics, and more.

The facet-joint injection market research report is one of a series of new reports from The Business Research Company that provides facet-joint injection market statistics, including the facet-joint injection industry global market size, regional shares, competitors with the facet-joint injection market share, detailed facet-joint injection market segments, market trends, and opportunities, and any further data you may need to thrive in the facet-joint injection industry. This facet-joint injection market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The facet-joint injection market size has grown strongly in recent years. It will grow from $2.78 billion in 2024 to $2.97 billion in 2025 at a compound annual growth rate (CAGR) of 7.0%. The growth observed during the historic period can be attributed to the increasing incidence of chronic back and neck pain, greater adoption of minimally invasive pain treatments, an aging population experiencing spinal degeneration, improved access to image-guided injection techniques, and heightened awareness of non-surgical pain relief methods.

The facet-joint injection market size is expected to see strong growth in the next few years. It will grow to $3.85 billion in 2029 at a compound annual growth rate (CAGR) of 6.7%. The projected growth in the forecast period is driven by rising demand for non-opioid pain management options, greater adoption of image-guided injection technologies, increased emphasis on outpatient and day-care procedures, expanded use of regenerative injection therapies, and growing healthcare investments in treatments for spinal disorders. Key trends expected during this time include improvements in ultrasound and fluoroscopy-guided injections, development of advanced drug formulations for longer-lasting pain relief, creation of combination therapies for joint pain, innovations in regenerative treatments like platelet-rich plasma and stem cells, and progress in wearable technology for monitoring after injections.

The increasing prevalence of spinal diseases and chronic back pain is expected to drive the growth of the facet-joint injection market going forward. These conditions, which include disc degeneration, arthritis, and nerve compression, cause ongoing pain, limited mobility, and a lower quality of life. The rise in spinal diseases and chronic back pain is largely attributed to sedentary lifestyles and poor posture, prompting more individuals to seek effective, minimally disruptive treatments that alleviate persistent discomfort and restore movement. Facet-joint injections provide relief by reducing pain and inflammation in the spine, helping those affected by these growing spinal health issues. For example, in May 2023, Spinal Cord Inc., a U.S.-based non-profit resource center, reported that approximately 18,000 new spinal cord injury cases occur annually in the United States, with an estimated 302,000 people living with spinal cord injuries nationwide. As a result, the increasing prevalence of spinal diseases and chronic back pain is fueling the expansion of the facet-joint injection market.

The increasing demand for minimally invasive procedures is expected to drive the growth of the facet-joint injection market in the coming years. Minimally invasive procedures involve medical treatments performed through small incisions or without large surgical cuts. Their popularity is rising due to patients' preference for quicker recovery and less post-operative pain. Facet-joint injections support these procedures by offering precise pain relief and diagnostic clarity without requiring extensive surgery. For example, in 2023, the American Society of Plastic Surgeons, a U.S.-based specialty organization, reported that the number of minimally invasive cosmetic procedures increased from 23.7 million in 2022 to 25.4 million in 2023. Consequently, the growing demand for minimally invasive treatments is fueling the expansion of the facet-joint injection market.

Key players in the facet-joint injection market are concentrating on creating innovative solutions, such as facet fusion systems, to provide longer-lasting relief and enhance treatment effectiveness. Facet fusion systems are medical devices designed to stabilize and fuse the facet joints by encouraging bone growth between neighboring vertebrae. For example, in March 2025, Aurora Spine Corporation, a U.S.-based medical device manufacturer, announced that its latest product, the AERO(TM) Facet Fusion System, received 510(k) clearance from the U.S. Food and Drug Administration (FDA). This system features a titanium plasma spray coating to enhance osseointegration and fusion potential. It also offers multiple implant sizes to fit different patient anatomies and includes radiolucent instruments to improve visibility during surgery. Together, these features aim to increase procedural efficiency and improve long-term outcomes in the treatment of chronic back pain caused by facet joint disorders.

Major players in the facet-joint injection market are Pfizer Inc., Merck & Co. Inc, AbbVie Inc., Sanofi S.A., Medtronic plc, Stryker Corporation, Teva Pharmaceutical Industries Ltd., Boston Scientific Corporation, Henry Schein Inc., Bausch Health Companies Inc., Zimmer Biomet Holdings Inc., Smith & Nephew plc, Dr. Reddy's Laboratories Ltd., Arthrex Inc., Aspen Pharmacare Holdings Limited, Pacira BioSciences Inc., Bioventus Inc., Ferring Pharmaceuticals, Anika Therapeutics Inc., Symbiotec Pharmalab Pvt. Ltd.

North America was the largest region in the facet-joint injection market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in facet-joint injection report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the facet-joint injection market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The facet-joint injection market consists of revenues earned by entities through medication management, rehabilitation and psychological counseling, and interventional procedures. The market value includes the value of related goods sold by the service provider or included within the service offering. The facet-joint injection market also includes of sales of injection kits, imaging guidance systems, patient monitoring devices, and pain-relieving medications. Values in this market are 'factory gate' values, meaning the value of goods sold by the manufacturers or creators, whether to other companies (like distributors, clinics, and hospitals) or directly to end users. The value of goods in this market also includes related services provided by the creators, such as training or support for the use of injection products.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Facet-Joint Injection Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on facet-joint injection market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for facet-joint injection ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The facet-joint injection market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Corticosteroids; Local Anesthetics; Hyaluronic Acid; Other Product Types
• 2) By Application: Cervical Facet Joints; Thoracic Facet Joints; Lumbar Facet Joints; Facet Joint Injections
• 3) By End-User: Hospitals; Ambulatory Surgical Centers; Specialty Clinics; Other End-Users
• Subsegments:
• 1) By Corticosteroids: Triamcinolone Acetonide; Methylprednisolone Acetate; Dexamethasone Sodium Phosphate; Betamethasone; Other Corticosteroids
• 2) By Local Anesthetics: Lidocaine; Bupivacaine; Ropivacaine; Prilocaine; Other Local Anesthetics
• 3) By Hyaluronic Acid: High Molecular Weight Hyaluronic Acid; Low Molecular Weight Hyaluronic Acid; Cross-Linked Hyaluronic Acid; Non-Cross-Linked Hyaluronic Acid
• 4) By Other Product Types: Platelet-Rich Plasma; Biological Agents; Combination Formulations; Other Injectables
• Companies Mentioned: Pfizer Inc.; Merck & Co. Inc; AbbVie Inc.; Sanofi S.A.; Medtronic plc
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Facet-Joint Injection Market Characteristics

3. Facet-Joint Injection Market Trends And Strategies

4. Facet-Joint Injection Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Facet-Joint Injection Growth Analysis And Strategic Analysis Framework

• 5.1. Global Facet-Joint Injection PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Facet-Joint Injection Market Growth Rate Analysis
• 5.4. Global Facet-Joint Injection Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Facet-Joint Injection Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Facet-Joint Injection Total Addressable Market (TAM)

6. Facet-Joint Injection Market Segmentation

• 6.1. Global Facet-Joint Injection Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Corticosteroids
• Local Anesthetics
• Hyaluronic Acid
• Other Product Types
• 6.2. Global Facet-Joint Injection Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cervical Facet Joints
• Thoracic Facet Joints
• Lumbar Facet Joints
• Facet Joint Injections
• 6.3. Global Facet-Joint Injection Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
• Other End-Users
• 6.4. Global Facet-Joint Injection Market, Sub-Segmentation Of Corticosteroids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Triamcinolone Acetonide
• Methylprednisolone Acetate
• Dexamethasone Sodium Phosphate
• Betamethasone
• Other Corticosteroids
• 6.5. Global Facet-Joint Injection Market, Sub-Segmentation Of Local Anesthetics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Lidocaine
• Bupivacaine
• Ropivacaine
• Prilocaine
• Other Local Anesthetics
• 6.6. Global Facet-Joint Injection Market, Sub-Segmentation Of Hyaluronic Acid, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• High Molecular Weight Hyaluronic Acid
• Low Molecular Weight Hyaluronic Acid
• Cross-Linked Hyaluronic Acid
• Non-Cross-Linked Hyaluronic Acid
• 6.7. Global Facet-Joint Injection Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Platelet-Rich Plasma
• Biological Agents
• Combination Formulations
• Other Injectables

7. Facet-Joint Injection Market Regional And Country Analysis

• 7.1. Global Facet-Joint Injection Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Facet-Joint Injection Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Facet-Joint Injection Market

• 8.1. Asia-Pacific Facet-Joint Injection Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Facet-Joint Injection Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Facet-Joint Injection Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Facet-Joint Injection Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Facet-Joint Injection Market

• 9.1. China Facet-Joint Injection Market Overview
• 9.2. China Facet-Joint Injection Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Facet-Joint Injection Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Facet-Joint Injection Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Facet-Joint Injection Market

• 10.1. India Facet-Joint Injection Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Facet-Joint Injection Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Facet-Joint Injection Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Facet-Joint Injection Market

• 11.1. Japan Facet-Joint Injection Market Overview
• 11.2. Japan Facet-Joint Injection Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Facet-Joint Injection Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Facet-Joint Injection Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Facet-Joint Injection Market

• 12.1. Australia Facet-Joint Injection Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Facet-Joint Injection Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Facet-Joint Injection Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Facet-Joint Injection Market

• 13.1. Indonesia Facet-Joint Injection Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Facet-Joint Injection Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Facet-Joint Injection Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Facet-Joint Injection Market

• 14.1. South Korea Facet-Joint Injection Market Overview
• 14.2. South Korea Facet-Joint Injection Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Facet-Joint Injection Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Facet-Joint Injection Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Facet-Joint Injection Market

• 15.1. Western Europe Facet-Joint Injection Market Overview
• 15.2. Western Europe Facet-Joint Injection Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Facet-Joint Injection Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Facet-Joint Injection Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Facet-Joint Injection Market

• 16.1. UK Facet-Joint Injection Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Facet-Joint Injection Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Facet-Joint Injection Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Facet-Joint Injection Market

• 17.1. Germany Facet-Joint Injection Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Facet-Joint Injection Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Facet-Joint Injection Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Facet-Joint Injection Market

• 18.1. France Facet-Joint Injection Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Facet-Joint Injection Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Facet-Joint Injection Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Facet-Joint Injection Market

• 19.1. Italy Facet-Joint Injection Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Facet-Joint Injection Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Facet-Joint Injection Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Facet-Joint Injection Market

• 20.1. Spain Facet-Joint Injection Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Facet-Joint Injection Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Facet-Joint Injection Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Facet-Joint Injection Market

• 21.1. Eastern Europe Facet-Joint Injection Market Overview
• 21.2. Eastern Europe Facet-Joint Injection Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Facet-Joint Injection Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Facet-Joint Injection Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Facet-Joint Injection Market

• 22.1. Russia Facet-Joint Injection Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Facet-Joint Injection Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Facet-Joint Injection Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Facet-Joint Injection Market

• 23.1. North America Facet-Joint Injection Market Overview
• 23.2. North America Facet-Joint Injection Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Facet-Joint Injection Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Facet-Joint Injection Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Facet-Joint Injection Market

• 24.1. USA Facet-Joint Injection Market Overview
• 24.2. USA Facet-Joint Injection Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Facet-Joint Injection Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Facet-Joint Injection Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Facet-Joint Injection Market

• 25.1. Canada Facet-Joint Injection Market Overview
• 25.2. Canada Facet-Joint Injection Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Facet-Joint Injection Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Facet-Joint Injection Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Facet-Joint Injection Market

• 26.1. South America Facet-Joint Injection Market Overview
• 26.2. South America Facet-Joint Injection Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Facet-Joint Injection Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Facet-Joint Injection Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Facet-Joint Injection Market

• 27.1. Brazil Facet-Joint Injection Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Facet-Joint Injection Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Facet-Joint Injection Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Facet-Joint Injection Market

• 28.1. Middle East Facet-Joint Injection Market Overview
• 28.2. Middle East Facet-Joint Injection Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Facet-Joint Injection Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Facet-Joint Injection Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Facet-Joint Injection Market

• 29.1. Africa Facet-Joint Injection Market Overview
• 29.2. Africa Facet-Joint Injection Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Facet-Joint Injection Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Facet-Joint Injection Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Facet-Joint Injection Market Competitive Landscape And Company Profiles

• 30.1. Facet-Joint Injection Market Competitive Landscape
• 30.2. Facet-Joint Injection Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Merck & Co. Inc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis

31. Facet-Joint Injection Market Other Major And Innovative Companies

• 31.1. Stryker Corporation
• 31.2. Teva Pharmaceutical Industries Ltd.
• 31.3. Boston Scientific Corporation
• 31.4. Henry Schein Inc.
• 31.5. Bausch Health Companies Inc.
• 31.6. Zimmer Biomet Holdings Inc.
• 31.7. Smith & Nephew plc
• 31.8. Dr. Reddy's Laboratories Ltd.
• 31.9. Arthrex Inc.
• 31.10. Aspen Pharmacare Holdings Limited
• 31.11. Pacira BioSciences Inc.
• 31.12. Bioventus Inc.
• 31.13. Ferring Pharmaceuticals
• 31.14. Anika Therapeutics Inc.
• 31.15. Symbiotec Pharmalab Pvt. Ltd.

32. Global Facet-Joint Injection Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Facet-Joint Injection Market

34. Recent Developments In The Facet-Joint Injection Market

35. Facet-Joint Injection Market High Potential Countries, Segments and Strategies

• 35.1 Facet-Joint Injection Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Facet-Joint Injection Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Facet-Joint Injection Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer